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ABSTRACT 
Objective: Type 2 diabetes evolves through a phase of normoglycemia and impaired glucose tolerance due to vitamin D deficiency. It was believed 
that sun light exposure is the natural way to improve the blood 25 (OH) D levels which delay or prevent disease progression. The study was to 
assess the effect of sunlight exposure in South Indian prediabetic population. 
Methods: Data of the subjects were retrospectively collected in three continuous intervals. Total 160 subjects were identified as prediabetes based 
on inclusion and exclusion criteria. Age between 30 to 65 years subjects was randomly recruited for the study. Subjects were assigned into two 
groups based on sunlight exposure. All anthropometric and metabolic parameters were measured and interpreted. 
Results: Between the group and within the group variation was assessed. In Comparative analysis sun light exposure group showed significant 
improvement in BMI (P=0.0309), glucose (P<0.0001), HbA1c (P<0.0001) and systolic BP (P=0.0042) were showed significant effect but not in 
diastolic BP (p>0.2893). In lipid profile, cholesterol (P=0.0002) and triglyceride (P=0.0019) showed significant improvement, but no significant 
effect was observed in HDL (P= 0.131), LDL (P=0.4735) level in sun light exposure group. 
Conclusion: Daily exposure of sunlight can improve the disease condition. Along with sunlight exposure, intensive life style changes and 
appropriate vitamin D supplementation may need to prevent or delay the disease progression. 
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INTRODUCTION 
Prediabetes occurs when glucose levels more than the normal level 
but not considered as diabetes, mainly because of insulin resistance 
and insulin sensitivity. People with prediabetes have an increased 
risk of developing Type 2 diabetes and heart diseases [1,14,17]. It 
has been estimated that 380 million individuals would be affected 
with diabetes worldwide by the year 2025. In India, it is expected to 
affect 70 million by the year 2025 [2]. It can be delayed or prevented 
through lifestyle modification, dietary change, weight loss, exercise 
and metformin intervention. In a three arm study, the lifestyle 
intervention group had 58 % of reduction in the incidence of 
diabetes [3]. 
Vitamin D insufficiency has been suspected to be a high risk factor 
for type 1 diabetes. Higher incidence and prevalence of type 1 
diabetes were identified in countries at higher latitude [4]. There 
was a seasonal variation develop type 1 diabetes, most commonly 
diagnosed in the winter, which suggests an effect of lower sunshine 
in associated with lower vitamin D status [5,6,7,18]. Increased 
insulin resistance, systemic inflammation and HbA1c level were 
found in patients with type 2 diabetes and Vitamin-D deficiency [8]. 
Major risk factor for prediabetes is obesity, which is commonly 
associated with hypovitaminosis due to the capacity of adipose 
tissue to store 25-hydroxy vitamin-D [9]. A decreased amount of 
serum 25 (OH) D can stimulate lipogenesis predisposing a patient to 
further weight gain and thus increasing the risk of diabetes [10]. 
Administration of vitamin-D has been shown to decrease insulin 
resistance in diabetic patients [11]. Vitamin D activates the 
pancreatic β cell function through the vitamin D receptor and 1-
alpha-hydroxylase, which is expressed in beta cells and also it 
enhances insulin sensitivity by stimulating insulin receptors and by 
activating peroxisome proliferators activated receptor (PPAR). 
Vitamin D may also affect insulin secretion and sensitivity indirectly 
through regulating extracellular calcium concentration in the beta 
cells and peripheral insulin-target tissues. [12]. Sunlight exposure is 
the natural way to increase serum 25(OH) D concentrations [13]. 
Hence the present study was aimed to suggest whether the sun light 
exposure of vitamin D utilization can reduce or prevent the 
predisposing of patients from prediabetic to diabetic and other 
cardiovascular diseases. 
MATERIALS AND METHODS 
Study site and duration 
This retrospective observational study includes all cases diagnosed 
as prediabetes in a period of three years from January 2010 to 
December 2013. Data of the patients were retrospectively collected 
from the Medical Record Department and Department of 
Endocrinology, PSG hospital, Coimbatore which is a tertiary care 
teaching hospital. The study was approved by Human ethics 
committee PSG IMS&R (IHEC 13/381). The data were compiled in 
proforma which included details of the patients, symptom analysis, 
clinical findings, investigations and management. Patient data were 
collected in three continuous visits after diagnosed as prediabetes  
Subjects 
In total, 160 subjects were identified as prediabetes from the clinical 
reports based on inclusion and exclusion criteria. The subjects were 
included age between 30 to 65 years and glucose level >100mg/dl to 
<125mg/dl were randomly recruited. Subjects were excluded if 
chronic alcoholism, hepatic failure, cardiovascular diseases and 
renal disorder. Patients receiving only written advice from the 
physician for lifestyle change considered for the study. Patients were 
classified into two groups based on their sun light exposure. The 
first was prediabetic group (n=80) and the second group was 
prediabetic patients exposed to sunlight (n=80) frequently in their 
routine life. All anthropometric parameters were obtained while the 
medical record was assessed.  
Statistical analysis 
Documented data were analyzed by using Analysis of Variance 
(ANOVA) and Student‘t’ test by using prism software (user guide 
6.1). Statistical significance was taken at the 95% level (P < 0.05). 
Results were expressed as Mean ± Standard Deviation. 
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RESULTS  
Changes of metabolic parameter in prediabetic patients without 
sun light exposure  
The study result showed most of them belongs to the age group 
between 25 and 35 years (42.3%). Female patients (53.75%) were 
more than the male patients (46.25%) in prediabetic condition. 
Based on the guideline, we found Subjects predisposed to T2DM 
(77.5%), hypertension (81%) and dyslipidemia (40%). Between the 
groups variation was observed in three continuous visits. Significant 
increase of Body weight (p<0.05), BMI range (p<0.001), Glucose 
level (p<0.001), HbA1c (p<0.001) was observed. In blood pressure 
level, systolic BP increased significantly (p<0.05) but in diastolic BP 
there was no significant change was observed (p>0.05). In lipid 
profile evaluation, significant increase of triglyceride (p<0.001) and 
cholesterol (p<0.05) was observed but rest of the parameters HDL 
(p>0.05) and LDL (p>0.05) was showing changes in each visit but 
statistically not significant. (Table -1) 
  
Table 1: Changes of Metabolic parameters in Prediabetic group 
 
 
Prediabetic Group  
P Value Visit1 Visit 2 Visit 3 
N 180    
Age 56.94±14.15    
Sex (M/F) 43(37)    
Weight (Kg) 67.33±7.02 68.93±7.24 70.88±7.96 0.05  
BMI (Kg/m2 25.8±1.4 ) 26.5±1.4 27.3±1.6 0.0003  
Blood glucose (Mmol/L) 6.3±0.3 7.2±1.1 7.7±13 0.0001 
HBA1c (%) 5.6±0.3 6.2±0.7 6.5±0.7 0.0001 
Blood pressure (mmHg)     
Systolic pressure 116.1±15.2 122.7±13.7 127.4±18.9 0.0328 
Diastolic pressure 78.7±10 80±7.6 80.8±7.5 0.5711(NS) 
Lipid profile      
Total CHO (Mmol/L) 4.55±.31 4.65±.27 4.66±.31 0.2211(NS) 
LDL (Mmol/L) 2.94±.34 3.0±.32 3.0±.31 0.2533(NS) 
HDL(Mmol/L) 1.25±.17 1.23±.15 1.18±0.14 0.1977(NS) 
TG (Mmol/L) 1.34±.12 1.43±.11 1.51±.11 0.0001 
Note: Data presented as mean ± standard error; NS – not significant; significance at p < 0.05. To convert the values for glucose to millimoles per 
liter, multiply by 0.05551. To convert the values for triglycerides to millimoles per liter, multiply by 0.01129. To convert the values for cholesterol to 
millimoles per liter, multiply by 0.02586. 
 
Table 2: Changes of Metabolic parameters in Prediabetic patients exposed to Sunlight 
 
 
Sun light Exposed Group  
P Value Visit 1 Visit 2 Visit 3 
N 80    
Age 47.08±13.21    
sex(M/F) 49(31)    
Weight (Kg) 63.86±7.67 63.7±7.9 63.13±7.6  
BMI (Kg/m2 25.1±1.4 ) 25.6±1.2 25±1.4 0.3819 (NS) 
Blood glucose (Mmol/L) 6.29±0.4 6.27±.43 6.24±.46 0.8757(NS) 
HBA1c (%) 5.57±.27 5.5±.26 5.5±.28 0.8184(NS) 
Blood pressure      
Systolic pressure (mmHg) 127±21.67 122.11±18.8 118.86±14.44 0.1313(NS) 
Diastolic pressure (mmHg) 78.97±10.5 78.69±7.85 78.69±7.8 0.9882(NS) 
Lipid profile     
Total CHO (Mmol/L) 4.42±0.32 4.46±0.31 4.49±0.32 0.614(NS) 
LDL (Mmol/L) 2.87±0.37 2.86±0.34 2.86±0.34 0.9738(NS) 
HDL(Mmol/L) 1.30±0.17 1.3±0.15 1.31±0.15 0.9873(NS) 
TG (Mmol/L) 1.24±0.12 1.25±0.11 1.2±0.10 0.9049(NS) 
Note: Data presented as mean ± standard error; NS – not significant; significance at p < 0.05. To convert the values for glucose to millimoles per 
liter, multiply by 0.05551. To convert the values for triglycerides to millimoles per liter, multiply by 0.01129. To convert the values for cholesterol to 
millimoles per liter, multiply by 0.02586. 
 
Changes of metabolic parameter in prediabetic patients with 
sun light exposure group 
Most of the subjects belong to the age group between 35 and 45 
years (54.3%). Male (61.25%) patients were more than the female 
(38.75%) patients in sun exposed group. Subjects predisposed to 
T2DM (52.5%), hypertension (51%) and dyslipidemia (35%) was 
observed. Only Body weight showed significant improvement 
(p<0.05) but no significant improvement were observed in BMI 
range (p>0.05), glucose level (p>0.05), HbA1c (p>0.05). In blood 
pressure level, both systolic and diastolic BP showed no significant 
changes (p>0.05) the steady state level was observed. In lipid profile 
evaluation, gradual improvement was observed in all the metabolic 
parameters but statistically no significant changes were observed 
triglyceride (p>0.05), cholesterol (p>0.05), HDL (p>0.05) LDL 
(p>0.05). (Table -2) 
Comparative analysis on prediabetic and sun light exposed 
group  
Comparative analysis was made between prediabetic and sun light 
exposure group. Significant improvement in BMI (2.95%, P = 
0.0309), glucose (10.54%, P<0.0001), HbA1c (11.10%, P<0.0001) 
and systolic BP (4.81%, P=0.0042) was observed in sun light 
exposed group but not in diastolic BP. In lipid profile, cholesterol 
(4.41%, P=0.0002) and triglyceride (4.27%, P=0.0019) produced 
significant improvement in sun light exposed group but no 
significant change was found in HDL (1.42%, P= 0.131), LDL (0.68%, 
P=0.4735) level (Table-4). Subjects significantly predisposed to 
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hypertension (p<0.05) and T2DM (p<0.01) was observed in 
prediabetic group than sun light exposed group but significant 
changes was not observed in dyslipidemic condition in both the 
groups. (Table-3) 
  
Table 3: Changes in risk factors at the end of third visit 
 Prediabetic group Sun light Exposed group  


















Type2 Diabetes Mellitus 34(79%) 28(75.6%) 24(48.9%) 17(54.8%) P<0.01 
Dyslipidemia 14(32.5%) 18(48.6) 15(30.6%) 13(41.9%) P>0.5(NS) 
Note: Data presented as percentages (%). NS – not significant; significance at p < 0.05. End of the third visit Patients Predisposed to metabolic 
disorder. Conditions are obtained based on the diabetes, hypertension and dyslipidemic guidelines. 
 
Table 4: Comparative analysis between the prediabetic and sun light exposed group 
 Comparison score (%) P value 
BMI 2.95 0.0309 
Blood glucose 10.54 P<0.0001 
HbA1c 11.10 P<0.0001 
Systolic BP 4.81 0.0042 
Diastolic BP 1.09 0.2893 (NS) 
Cholesterol 4.41 0.0002 
HDL 1.42 0.131 (NS) 
LDL 0.68 0.4735 (NS) 
TG 4.27 0.0019 
Note: Data presented as percentages (%). NS – not significant; significance at p < 0.05. 
 
DISCUSSION  
In our study rate of improvement was less in the female than male 
subjects in sun exposure group. This may be explained by limited 
skin exposure due to skin-covering clothes and by limited sunlight 
exposure. In fact, a poor vitamin D status can be seen in pigmented 
persons even in regions with abundant sunshine [15]. Blood glucose 
level was remained unvarying in sun exposure group in contrast to 
the prediabetic group. Periodic sun light exposure supposes to be 
improved the blood glucose at a halt. Chel et al study has shown 
ultraviolet irradiation is as effective as vitamin D supplementation in 
geriatric patients [28]. Hence this study also chains with Vitamin-D 
is related with insulin resistance and HbA1c in patients of T2DM 
[19]. In contrast, Reis et al and Wareham et al reported no 
association of 25(OH) D with metabolic syndrome. [25, 26]. Ford et 
al, in a study of 7904 individuals reported 25(OH) D to be inversely 
associated with metabolic syndrome [27]
Body mass index ratio was maintained and no further increase of 
body weight was observed in sun light exposure group. It 
demonstrated that vitamin D may increases the lipolysis and reduce 
the expression of Matrix metalloproteinase (MMPs) enzymes like 
MMP-2, MMP-8, MMP-9 and lower plasma tissue inhibitor of 
metalloproteinase 1 (TIMP-1) which is involved in the pathogenesis 
of obesity [19,20] leads to cause type 2 diabetes. In addition to that, 
diabetic prevention program (DPP) study have shown that weight loss 
was an effective method for reducing the incidence of diabetes [21]. 
Sun light Significantly decreased the HbA1c level in patient with 
prediabetes it could be due to sun light exposure reduces association 
of glucose with hemoglobin which decreased blood glucose level 
gradually [22]. Consistent weekly exposure of sun light may be 
beneficial effect to maintain healthy vitamin D levels in the blood [16]. 
. These controversial 
reports may be explained by the differences in race, BMI, blood 
sugars, sunlight exposure and obesity.  
Steady state level of systolic and diastolic BP indicates, sun light 
increases the production of vitamin D (25(OH) D) in body cells 
which are actively participating in control of renin release which 
decreases blood pressure by regulating aldosterone secretions [23]. 
Exposure of UV-A for six weeks, 3 times weekly increased vitamin D 
level in the blood has been shown to reduce blood pressure when 
compare to UV-B exposure which does not produce vitamin D [24]. 
In our study sunlight exposure was not associated with majority of 
the metabolic parameters measured, with only triglycerides showing 
a positive association among patients with prediabetes which is 
supporting Al-Daghri et al study, additional finding of this study was 
negligible improvement of total cholesterol which could be due to 
south Indian populations exposed more to UV radiation and the 
blood 25 (OH) D levels are relatively higher compared with other 
populations [29]. Consequently there was a possibility an intensive 
life style modification in sun exposure or vitamin D supplementation 
might improve the total cholesterol and other metabolic parameters. 
Predisposed to T2DM and cardiovascular disease was less in 
subjects exposed to sun light which may possibly due to vitamin D 
improving insulin resistance and sensitivity and blood pressure 
regulations [17]. 
CONCLUSION 
In this study, we found that exposure to sunlight itself was not very 
effective, intensive life style changes and appropriate vitamin D 
supplementation may need to prevent or delay the disease 
progression. Although this study indicates association of sunlight 
and dyslipidemia are contradictory and unclear. Further prospective 
studies are required for confirming these findings. 
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ABBREVIATIONS 
UV-A&B - Ultraviolet radiation A & B 
T2DM- Type 2 diabetes Mellitus  
25 (OH) D- 25-hydroxy vitamin D 
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PPAR -Peroxisome proliferators activated receptor  
BP- Blood pressure 
DPP- Diabetic prevention program 
MMPs - Matrix metalloproteinase  
TIMP-1-Tissue inhibitor of metalloproteinase 1  
HbA1c- Hemoglobin A1c 
HDL- High density lipoprotein 
LDL- Low density lipoprotein 
BMI- Body mass index 
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